This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Stichting Vumc. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Stewart Thomas Cole: Innovator in Mycobacterial Research
Introduction
Stewart Thomas Cole is a notable inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of medical research, particularly in the area of mycobacterial infections. His innovative work has led to the development of a patent that addresses critical health challenges.
Latest Patents
Cole holds a patent for the "Inhibition of mycobacterial type VII secretion." This invention relates to compounds and pharmaceutically acceptable salts thereof, along with their medical applications. The exemplary medical uses include the prevention and treatment of bacterial infections, specifically mycobacterial infections that can affect the respiratory system and other areas. The patent also covers the use of these compounds as chemotherapeutic agents, highlighting their potential in inhibiting mycobacterial type VII secretion.
Career Highlights
Throughout his career, Stewart Thomas Cole has worked with prominent institutions such as Stichting VUmc and Stichting Amsterdam UMC. His research has focused on developing innovative solutions to combat bacterial infections, showcasing his commitment to advancing medical science.
Collaborations
Cole has collaborated with notable colleagues, including Eelco Ruijter and Mark Karsten Rong. These partnerships have contributed to the success of his research and the development of his patented inventions.
Conclusion
Stewart Thomas Cole's contributions to the field of mycobacterial research exemplify the impact of innovation in medicine. His patent for inhibiting mycobacterial type VII secretion represents a significant advancement in the treatment of bacterial infections.